ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Agentic Platform Engineer at Eli Lilly and Company - ApplyBlast

Senior Agentic Platform Engineer

Eli Lilly and Company

1 month ago

4.0 on Glassdoor

Hyderabad, Telangana, India

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This senior individual-contributor role owns the end-to-end agentic resolution platform, encompassing both the cloud-native infrastructure and the intelligent agents that operate on it. The position involves designing production LLM patterns, architecting scalable Kubernetes environments, and establishing robust CI/CD and observability frameworks to drive automation and reduce operational toil. Success in this role is measured by improved deflection rates, sustained platform availability, and enhanced developer velocity through strategic technical leadership.

Responsibilities

Architect and operate the agentic resolution platform end to end
Design production LLM application patterns and knowledge strategies
Build and maintain cloud-native infrastructure and CI/CD pipelines

Skills

Qualifications

Bachelor's degree or higher in Computer Science, Information Technology, or a closely related field

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.